Skip to main content
. 2015 Dec 28;12:S111–S198. doi: 10.1111/j.1470-9465.2006.12_4_1427.x

Entembacleriaceae
Acinetobacter spp.

In patients
Out patients
In patients
Out patients

(n=1,920)
(n=360)
(n=345)
(n=39)
%S MIC90 %S MIC90 %S MIC90 %S MIC90
Tigecycline 95.9 1 98.3 1 99.7 1 99.4 2

Amikacin 99.5 4 98.6 4 74.5 >64 87.2 32

Cefepime 94.2 4 94.2 4 55.7 32 66.7 32

Ceftazidime 83.4 32 86.4 32 55.9 >32 71.8 >32

Imipeneml 99.3 1 100 1 82.6 16 94.9 4

Levofloxacin 86.2 8 83.4 4 58.3 >8 76.9 8

Minocycline 83.5 8 85.8 8 89.6 8 94.9 2

PipTazo 86.5 64 90.3 16 68.1 >128 84.6 >128


S aureus
Enterococcus spp.

In patients
Out patients
In patients
Out patients

(n=514)
(n=146)
(n=360)
(n=49)
%S I MIC90 %S MIC90 %S MIC90 %S MIC90
Tiqecycline 100 0.25 100 0.25 95.9 0.25 100 0.12

Levofloxacin 67.5 16 76 8 69.4 >32 63 >32

Linezolid 100 4 100 2 98 2 100 2

Minocycline 99.4 0.5 100 1 42.9 >8 37 >8

Vancomycin 100 1 100 1 98 2 100 2